135 related articles for article (PubMed ID: 38678336)
1. [Cutaneous ALK rearranged spindle cell neoplasm and S-100/CD34 co-expression: report of a case].
Zhang W; Wang Y; Wang H; Gao Y; Chen YL
Zhonghua Bing Li Xue Za Zhi; 2024 May; 53(5):498-500. PubMed ID: 38678336
[TBL] [Abstract][Full Text] [Related]
2. Novel PPP1CB-ALK fusion in spindle cell tumor defined by S100 and CD34 coexpression and distinctive stromal and perivascular hyalinization.
Lopez-Nunez O; Surrey LF; Alaggio R; Fritchie KJ; John I
Genes Chromosomes Cancer; 2020 Aug; 59(8):495-499. PubMed ID: 32222087
[TBL] [Abstract][Full Text] [Related]
3. S100/CD34-Positive Spindle Cell Mesenchymal Neoplasm Harboring KIAA1549-BRAF Fusion.
Paton DJW; Wong D; Amanuel B; Cheah K; Ardakani NM
Am J Dermatopathol; 2021 Mar; 43(3):217-220. PubMed ID: 33464748
[TBL] [Abstract][Full Text] [Related]
4. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
[TBL] [Abstract][Full Text] [Related]
5. BRAF-rearranged spindle cell mesenchymal neoplasm with a predominant lipofibromatosis-like neural tumor pattern and co-expression of CD34, S100 protein, and markers associated with perineurial differentiation: A rare case with potential diagnostic pitfall.
Sun K; Ru GQ; Zhao M
J Cutan Pathol; 2022 Mar; 49(3):278-283. PubMed ID: 34632612
[TBL] [Abstract][Full Text] [Related]
6. Molecular breakdown: a comprehensive view of anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer.
Noh KW; Lee MS; Lee SE; Song JY; Shin HT; Kim YJ; Oh DY; Jung K; Sung M; Kim M; An S; Han J; Shim YM; Zo JI; Kim J; Park WY; Lee SH; Choi YL
J Pathol; 2017 Nov; 243(3):307-319. PubMed ID: 28741662
[TBL] [Abstract][Full Text] [Related]
7. Anaplastic lymphoma kinase translocation is correlated with anaplastic lymphoma kinase expression and mutually exclusive with epidermal growth factor receptor mutation in Taiwanese non-small cell lung cancer.
Hsu SC; Hung TH; Wang CW; Ng KF; Chen TC
Pathol Int; 2015 May; 65(5):231-9. PubMed ID: 25708242
[TBL] [Abstract][Full Text] [Related]
8. A case report of atypical Spitz tumor harboring a novel MLPH-ALK gene fusion with discordant ALK immunohistochemistry results.
Fujimoto M; Togashi Y; Matsuzaki I; Baba S; Takeuchi K; Inaba Y; Jinnin M; Murata SI
Hum Pathol; 2018 Oct; 80():99-103. PubMed ID: 29514107
[TBL] [Abstract][Full Text] [Related]
9. A novel case of cutaneous myxoid spindle cell neoplasm with FMR1-ALK gene fusion and CD34/S100 co-expression.
Kasago I; Aypar U; Sukhadia P; Vanderbilt C; Ladanyi M; Hurd T; Pulitzer M
J Cutan Pathol; 2023 Jun; 50(6):505-510. PubMed ID: 36325885
[TBL] [Abstract][Full Text] [Related]
10. EML4-ALK testing in non-small cell carcinomas of the lung: a review with recommendations.
Thunnissen E; Bubendorf L; Dietel M; Elmberger G; Kerr K; Lopez-Rios F; Moch H; Olszewski W; Pauwels P; Penault-Llorca F; Rossi G
Virchows Arch; 2012 Sep; 461(3):245-57. PubMed ID: 22825000
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes in ALK-rearranged lung adenocarcinomas according to ALK fusion variants.
Cha YJ; Kim HR; Shim HS
J Transl Med; 2016 Oct; 14(1):296. PubMed ID: 27756333
[TBL] [Abstract][Full Text] [Related]
12. GAB1-ABL1 fusions in tumors that have histologic overlap with NTRK-rearranged spindle cell tumors.
Choo F; Rakheja D; Davis LE; Davare M; Park JY; Timmons CF; Neff T; Beadling C; Corless CL; Davis JL
Genes Chromosomes Cancer; 2021 Sep; 60(9):623-630. PubMed ID: 34036664
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance in anaplastic lymphoma kinase-rearranged lung cancer.
Katayama R
Cancer Sci; 2018 Mar; 109(3):572-580. PubMed ID: 29336091
[TBL] [Abstract][Full Text] [Related]
14. Superficial ALK-rearranged myxoid spindle cell neoplasm with a novel FMR1-ALK fusion gene.
Kao YC; Lee PH; Wu CL; Yu SC; Huang HY
Mod Pathol; 2022 Mar; 35(3):438-441. PubMed ID: 34937902
[No Abstract] [Full Text] [Related]
15. Molecular mechanisms that underpin EML4-ALK driven cancers and their response to targeted drugs.
Bayliss R; Choi J; Fennell DA; Fry AM; Richards MW
Cell Mol Life Sci; 2016 Mar; 73(6):1209-24. PubMed ID: 26755435
[TBL] [Abstract][Full Text] [Related]
16. Anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with the variant RNF213-, ATIC- and TPM3-ALK fusions is characterized by copy number gain of the rearranged ALK gene.
van der Krogt JA; Bempt MV; Ferreiro JF; Mentens N; Jacobs K; Pluys U; Doms K; Geerdens E; Uyttebroeck A; Pierre P; Michaux L; Devos T; Vandenberghe P; Tousseyn T; Cools J; Wlodarska I
Haematologica; 2017 Sep; 102(9):1605-1616. PubMed ID: 28659337
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of ALK rearrangement in Chinese non-small cell lung cancer using FISH, immunohistochemistry, and real-time quantitative RT- PCR on paraffin-embedded tissues.
Zhang YG; Jin ML; Li L; Zhao HY; Zeng X; Jiang L; Wei P; Diao XL; Li X; Cao Q; Tian XX
PLoS One; 2013; 8(5):e64821. PubMed ID: 23741400
[TBL] [Abstract][Full Text] [Related]
18. ALK-positive (2p23 rearranged) anaplastic large cell lymphoma with localization to the skin in a pediatric patient.
Pulitzer M; Ogunrinade O; Lin O; Steinherz P
J Cutan Pathol; 2015 Mar; 42(3):182-187. PubMed ID: 25404214
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Advanced Lung Squamous Cell Carcinoma with CLIP1-ALK Fusion Gene].
Yuan Y; Wang Z; Nie X; Zhang P; Li L
Zhongguo Fei Ai Za Zhi; 2022 Sep; 25(9):696-700. PubMed ID: 36172736
[TBL] [Abstract][Full Text] [Related]
20. ROS1 and ALK fusions in colorectal cancer, with evidence of intratumoral heterogeneity for molecular drivers.
Aisner DL; Nguyen TT; Paskulin DD; Le AT; Haney J; Schulte N; Chionh F; Hardingham J; Mariadason J; Tebbutt N; Doebele RC; Weickhardt AJ; Varella-Garcia M
Mol Cancer Res; 2014 Jan; 12(1):111-8. PubMed ID: 24296758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]